Degarelix Acetate

Micafungin Sodium, Anidulafungin-Fructose, Dalbavancin, Everolimus, Sarecycline, Midostaurin etc.

A tetracycline class antibacterial indicated for the treatment of adult patients with the following infections caused by susceptible microorganisms (1): Community-acquired bacterial pneumonia (CABP) (1.1); Acute bacterial skin and skin structure infections (ABSSSI) 

Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus ,  to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus and est...

Rezafungin is a next-generation, semi-synthetic, cyclic lipopeptide and echinocandin derivative, with potential antifungal activity. 

Glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. 

Indicated for the inhibition of premature LH surges in women undergoing controlled ovarian stimulation.

Indicated in Psoriatic Arthritis, Psoriasis and Oral Ulcers Associated with Behçet’s Disease

Diarylquinoline antimycobacterial drug indicated as part of combination therapy in the treatment of adult and pediatric patients (5 years and older and weighing at least 15 kg) with pulmonary multi-drug resistant tuberculosis (MDR-TB).

Indicated, in combination with encorafenib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation

Indicated for the treatment of partial-onset seizures in patients 4 years of age and older.

Used to prevent excessive bleeding after childbirth, particularly following Cesarean section.

Indicated for topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 3 months of age and older.

Brochure of the company for referring to Company's work profile, strengths, capabilities and facility information.